Advances in Diagnosing Non-melanoma Skin Cancers

Skin & Aging (Feb 9 2012) Dermatology , Oncology

1. 

   Biopsy remains the gold standard, but newer tools are useful adjuncts. More than 3.5 million skin cancers are diagnosed in more than 2 million patients in the United States each year, 1 and evidence from the American Academy of Dermatology (AAD) suggests that 20% of Americans will develop skin cancer. Basal cell and squamous cell carcinomas (BCC and SCC, respectively) are the two most common forms, accounting for about 96% of non-melanoma skin cancer (NMSC), and are easily treated, 2,3 with the latter more likely to spread to the lymph nodes. Both BCC and SCC are increasingly being ...

   (Read Full Article)

   Bookmark or Share this article

Login to comment.